Eli Lilly Receives FDA Orphan Designation for Humanized Immunoglobulin G4-Variant Monoclonal Antibody Directed Against P19 Subunit of Interleukin (IL)-23 in Treatment Of UC in Pediatric Patients
Charles Gross